Skip to main content
TipRanks
Go Ultimate75% OFF

bioMerieux (BMXMF) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

bioMerieux has a market cap or net worth of $11.77B. The enterprise value is $7.90B.

Market Cap
$11.77B
Enterprise Value
$7.90B

Share Statistics

bioMerieux has 118,361,220 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
118,361,220
Owned by Insiders
―
Owned by Institutions
8.18%

Financial Efficiency

bioMerieux’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 9.13%.

Return on Equity (ROE)
0.10
Return on Assets (ROA)
0.07
Return on Invested Capital (ROIC)
9.13%
Return on Capital Employed (ROCE)
0.12
Revenue Per Employee
273.25K
Profits Per Employee
26.69K
Employee Count
14,894
Asset Turnover
0.73
Inventory Turnover
1.98

Valuation Ratios

The current PE Ratio of bioMerieux is 23.07. bioMerieux’s PEG ratio is 0.99.

PE Ratio
23.07
PS Ratio
2.67
PB Ratio
2.48
Price to FCF
18.22
Price to Operating Cash Flow
11.76
PEG Ratio
0.99

Income Statement

In the last 12 months, bioMerieux had revenue of 4.07B and earned 397.50M in profits. Earnings per share was 3.37.

Revenue
4.07B
Gross Profit
2.14B
Operating Income
561.20M
Pretax Income
525.50M
Net Income
397.50M
EBITDA
999.60M
Earnings Per Share (EPS)
3.37

Cash Flow

In the last 12 months, operating cash flow was 907.60M and capital expenditures -322.10M, giving a free cash flow of 585.50M billion.

Operating Cash Flow
907.60M
Free Cash Flow
585.50M
Free Cash Flow per Share
4.97

Dividends & Yields

bioMerieux pays an annual dividend of $1.03, resulting in a dividend yield of 1.09%

Dividend Per Share
$1.03
Dividend Yield
1.09%
Payout Ratio
27.59%
Free Cash Flow Yield
5.49%
Earnings Yield
4.33%

Stock Price Statistics

Beta
0.35
52-Week Price Change
-18.53%
50-Day Moving Average
93.12
200-Day Moving Average
91.94
Relative Strength Index (RSI)
54.46
Average Volume (3m)
166

Important Dates

bioMerieux upcoming earnings date is Feb 26, 2027, Before Open (Not Confirmed).

Last Earnings Date
Jul 28, 2026
Next Earnings Date
Feb 26, 2027
Ex-Dividend Date
Jun 10, 2025

Financial Position

bioMerieux as a current ratio of 2.39, with Debt / Equity ratio of 11.25%

Current Ratio
2.39
Quick Ratio
1.47
Debt to Market Cap
0.02
Net Debt to EBITDA
-0.11
Interest Coverage Ratio
35.52

Taxes

In the past 12 months, bioMerieux has paid 128.80M in taxes.

Income Tax
128.80M
Effective Tax Rate
0.25

Enterprise Valuation

bioMerieux EV to EBITDA ratio is 11.38, with an EV/FCF ratio of 17.82.

EV to Sales
2.61
EV to EBITDA
11.38
EV to Free Cash Flow
17.82
EV to Operating Cash Flow
11.50

Balance Sheet

bioMerieux has $657.70M in cash and marketable securities with $421.80M in debt, giving a net cash position of $235.90M billion.

Cash & Marketable Securities
$657.70M
Total Debt
$421.80M
Net Cash
$235.90M
Net Cash Per Share
$1.99
Tangible Book Value Per Share
$26.55

Margins

Gross margin is 52.04%, with operating margin of 11.99%, and net profit margin of 11.59%.

Gross Margin
52.04%
Operating Margin
11.99%
Pretax Margin
15.21%
Net Profit Margin
11.59%
EBITDA Margin
22.98%
EBIT Margin
11.99%

Analyst Forecast

The average price target for bioMerieux is $98.46, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
$98.46
Price Target Upside
1.42% Downside
Analyst Consensus
Neutral
Analyst Count
7
Revenue Growth Forecast
3.86%
EPS Growth Forecast
31.52%